Cyclosporine Terminated Phase 3 Trials for Anti-r-HuEpo Associated PRCA Subjects Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01288131Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment